Anastomotic leakage | |||||
---|---|---|---|---|---|
Absent (n = 50) | Present (n = 16) | OR | 95% CI | P value | |
Age (years) | |||||
<65 | 20 (40%) | 8 (50%) | 1.500 | 0.484–4.651 | 0.483 |
≥65 | 30 (60%) | 8 (50%) | 1 | ||
Sex | |||||
Male | 42 (84%) | 15 (94%) | 2.857 | 0.329–24.795 | 0.341 |
Female | 8 (16%) | 1 (6%) | 1 | ||
Body mass index (kg/m2) | |||||
<22 | 24 (48%) | 10 (63%) | 1.806 | 0.569–5.726 | 0.316 |
≥ 22 | 26 (52%) | 6 (38%) | 1 | ||
Serum albumin level (g/dL) | |||||
<4 | 20 (40%) | 5 (31%) | 0.682 | 0.206–2.261 | 0.531 |
≥ 4 | 30 (60%) | 11 (69%) | 1 | ||
Brinkman index | |||||
<800 | 24 (48%) | 3 (19%) | 0.250 | 0.063–0.986 | 0.048 |
≥ 800 | 26 (52%) | 13 (81%) | 1 | ||
Performance status | |||||
0 | 42 (84%) | 13 (81%) | 0.825 | 0.191–3.574 | 0.797 |
1, 2 | 8 (16%) | 3 (19%) | 1 | ||
Diabetes | |||||
Absent | 39 (78%) | 13 (81%) | 1.222 | 0.295–5.069 | 0.782 |
Present | 11 (22%) | 3 (19%) | 1 | ||
Cardiovascular disease | |||||
Absent | 46 (92%) | 13 (81%) | 0.377 | 0.075–1.901 | 0.237 |
Present | 4 (8%) | 3 (19%) | |||
Obstructive ventilation failure | |||||
Absent | 36 (72%) | 9 (56%) | 0.500 | 0.156–1.603 | 0.243 |
Present | 14 (28%) | 7 (44%) | 1 | ||
ASA-PS score | |||||
1 | 3 (6%) | 1 (6%) | 1.044 | 0.101–10.806 | 0.971 |
2, 3 | 47 (94%) | 15 (94%) | 1 | ||
Histological type | |||||
Squamous cell carcinoma | 45 (90%) | 15 (94%) | 1.667 | 0.180–15.425 | 0.653 |
Others | 5 (10%) | 1 (6%) | 1 | ||
Tumor location | |||||
Ut, Mt | 31 (62%) | 11 (69%) | 1.348 | 0.406–4.484 | 0.626 |
Lt, Ae | 19 (38%) | 5 (31%) | 1 | ||
cT | |||||
1 | 21 (42%) | 9 (56%) | 1.776 | 0.570–5.531 | 0.322 |
2, 3, 4a | 29 (58%) | 7 (44%) | 1 | ||
cN | |||||
Absent | 33 (66%) | 10 (63%) | 0.859 | 0.267–2.764 | 0.798 |
Present | 17 (34%) | 6 (38%) | 1 | ||
cStage | |||||
1 | 20 (40%) | 9 (56%) | 1.929 | 0.618–6.020 | 0.258 |
2, 3 | 30 (60%) | 7 (44%) | 1 | ||
Neoadjuvant chemotherapy | |||||
Absent | 22 (44%) | 10 (63%) | 2.121 | 0.668–6.739 | 0.202 |
Present | 28 (56%) | 6 (38%) | 1 | ||
Abdominal approach | |||||
Open | 11 (22%) | 4 (25%) | 1.182 | 0.317–4.400 | 0.803 |
Laparoscopic | 39 (78%) | 12 (75%) | 1 | ||
Lymph node dissection | |||||
Two-field | 15 (30%) | 5 (31%) | 1.061 | 0.314–3.585 | 0.925 |
Three-field | 35 (70%) | 11 (69%) | 1 | ||
Route of reconstruction | |||||
Retrosternal | 43 (86%) | 15 (94%) | 2.442 | 0.277–21.519 | 0.421 |
Posterior mediastinal | 7 (14%) | 1 (6%) | 1 | ||
Shape of gastric tube | |||||
Wide | 5 (10%) | 3 (19%) | 2.077 | 0.437–9.871 | 0.358 |
Narrow | 45 (90%) | 13 (81%) | 1 | ||
Total operative time (min) | |||||
<600 | 20 (40%) | 6 (38%) | 0.900 | 0.282–2.870 | 0.859 |
≥ 600 | 30 (60%) | 10 (63%) | 1 | ||
Blood loss (mL) | |||||
<100 | 26 (52%) | 7 (44%) | 0.718 | 0.231–2.229 | 0.566 |
≥ 100 | 24 (48%) | 9 (56%) | 1 | ||
Anastomotic method | |||||
ICG circular group | 30 (60%) | 3 (19%) | 0.154 | 0.039–0.610 | 0.008 |
Classical group | 20 (40%) | 13 (81%) | 1 |